It’s not every day that a company’s stock price skyrockets nearly eightfold in less than a week, but that’s exactly what happened with Cosmorobotics, the South Korean wearable robot specialist, as it made its explosive debut on the KOSDAQ market this May. The company’s initial public offering (IPO) and subsequent trading days have drawn intense attention from investors and industry watchers alike, signaling both a renewed frenzy in the IPO market and a growing recognition of South Korea’s emerging leadership in robotics and healthcare technology.
Cosmorobotics, founded in 2016, develops wearable exoskeleton robots designed to support gait rehabilitation for patients suffering from stroke, spinal cord injuries, and cerebral palsy. What sets the company apart is its comprehensive product portfolio—covering everyone from preschool-aged children to the elderly, and even offering infant rehabilitation robots, a rarity in the global marketplace. Its flagship technology, the ‘Natural Gait’ control system, analyzes muscle movement, joint angles, and ground reaction forces in real time, enabling the robots to replicate natural human walking patterns. This innovation has been validated through domestic and international clinical studies and publications, earning Cosmorobotics a strong reputation for technical excellence.
When Cosmorobotics debuted on the KOSDAQ on May 11, 2026, it was already clear that the IPO would be a hot ticket. The company set its IPO price at 6,000 KRW, but by the time the opening bell rang, shares had soared to 24,000 KRW—quadruple the IPO price, a phenomenon known locally as ‘따따블’ or ‘double double’. The excitement didn’t stop there. Over the next two trading days, Cosmorobotics hit the daily upper price limit (상한가) consecutively, and by the morning of May 14, the stock was trading at 52,700 KRW, marking a staggering 778.33% increase from its IPO price. According to various outlets, including Biotimes and Hankyung, the company’s market capitalization crossed the 1.3 trillion KRW threshold, cementing its status as a new heavyweight in the tech sector.
The fervor was reflected in the numbers: during the public offering, Cosmorobotics drew a subscription competition rate of 2,013.8 to 1 from retail investors, pulling in an astonishing 6.3 trillion KRW in funds. Institutional investors, too, showed strong confidence, with 74.48% of shares subject to lock-up agreements, meaning early supply was tightly constrained. This scarcity effect—often described as the ‘품절주’ or ‘out-of-stock stock’ phenomenon—helped propel the share price even higher as eager buyers scrambled for limited available shares.
On the trading floor, the volatility was palpable. As reported by CBC News and MP Doctor, Cosmorobotics’ stock triggered volatility interruption (VI) mechanisms twice in the opening minutes of May 14, as prices surged past the 50,000 KRW mark. By 9:07 a.m., the stock was trading at 51,000 KRW, up 25.77% from the previous day, and within minutes, it had reached 52,700 KRW, the daily upper limit. The KOSDAQ and KOSPI indices themselves were buoyant, but Cosmorobotics was the undoubted star of the show.
Much of the market’s enthusiasm centers on Cosmorobotics’ unique position in the global wearable robotics industry. The company is the only Korean firm in its field to have secured both US FDA 510(k) and European CE certifications for its rehabilitation robots, a feat that only a handful of global competitors can claim. Its international focus is evident—about 69% of sales come from overseas, with subsidiaries in the US, Japan, Russia, Europe, and China, and partnerships in 13 countries. This global footprint, combined with the company’s aggressive expansion plans, has fueled expectations for continued growth.
Cosmorobotics’ ambitions extend beyond hospitals and rehabilitation centers. The company plans to use the 25.02 billion KRW raised in its IPO to develop new products and expand into business-to-consumer (B2C) and government/public (B2G) markets. Among the new offerings in the pipeline are the COSuit, a gait assistance robot; the COSaver, a care support robot; and even wearable robots designed to assist with ammunition transport in industrial settings. CEO Oh Joo-young articulated this vision at the company’s listing ceremony, stating, “We will use this IPO as a springboard to become a dominant global leader in the wearable robot sector and continue to fulfill our founding mission of offering new lives to those with walking difficulties.”
Analysts and observers have highlighted several factors underpinning Cosmorobotics’ meteoric rise. The convergence of artificial intelligence, advanced sensors, and robotics in healthcare is seen as a global megatrend, especially as populations age and chronic illnesses become more prevalent. Market watchers, including those cited by Biotimes, believe Cosmorobotics is well-positioned to ride this wave, with plans to grow at an annual rate exceeding 60% through 2028. The company’s ability to secure major global certifications and forge international partnerships is expected to be a key driver of future performance.
Yet, there are also notes of caution. As a technology-specialized listing, Cosmorobotics is still in the early stages of profitability stabilization. The pace of earnings improvement and the success of its overseas expansion will be crucial determinants of its long-term valuation. Still, the sheer scale of early investor interest and the company’s robust technological foundation suggest that Cosmorobotics is more than just a short-term market sensation.
Cosmorobotics’ debut comes amid a broader IPO boom in South Korea, with other companies like Polled also seeing dramatic opening day surges and fierce competition for shares. According to Korea Exchange and NH Investment & Securities, Polled’s own IPO saw a competition rate of 3,169.86 to 1 and an opening price four times its IPO level. The feverish demand for public offerings, fueled by abundant liquidity and a scarcity of new listings, has become a defining feature of the current Korean capital markets.
For now, Cosmorobotics stands as a symbol of both the promise and the volatility of the modern IPO market. With its blend of cutting-edge technology, global ambition, and investor excitement, the company is poised to play a leading role in the future of wearable robotics—if it can deliver on its lofty goals.